Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Thompson, C. Articles by McKendrick, J. Search for Related Content PubMed Citation Articles by Thompson, C. Articles by McKendrick, J. Primary Care Depression Antidepressants

Compliance With Antidepressant Medication in the Treatment of Major Depressive Disorder in Primary Care: A Randomized Comparison of Fluoxetine and a Tricyclic Antidepressant

OBJECTIVE: Many claims have been made for superior compliance with selective serotonin reuptake inhibitors (SSRIs) compared with tricyclic antidepressants, but to date meta-analyses have not confirmed reduced dropouts in randomized controlled trials. The authors used a randomized study design to evaluate differential compliance with antidepressant medications in a primary care setting. METHOD: A total of 152 patients treated in 10 primary care practices in the United Kingdom were included in a randomized, open-label, parallel-group study of fluoxetine and dothiepin at therapeutic doses for 12 weeks. Compliance was assessed by using pill count, patient questionnaires, and the Medication Event Monitoring System. RESULTS: The level of compliance with fluoxetine was numerically higher than the level of compliance with dothiepin on all three primary outcome measures, although the differences were not significant. In a secondary analysis using data from the Medication Event Monitoring System, both a survival analysis for length of time without a gap in medicine taking and a derived compliance index showed a significant advantage to fluoxetine. Patients in the fluoxetine group reported superior response on the health transition scale of the 36-item Short-Form Health Survey Questionnaire and numerically greater improvement on the Hamilton Depression Rating Scale. In both treatment arms patients with a superior compliance index were more likely to have improved in Hamilton depression scale scores by the last study visit. CONCLUSIONS: This study supports recent meta-analyses of SSRIs versus tricyclic antidepressants in finding no significant differences in crude indices of compliance between fluoxetine and dothiepin, despite marked differences in side effect profile and dose regimen. However, both a survival analysis and a new measure that takes account of prolonged periods of noncompliance distinguished between the treatments and was associated with improvement in both groups.

This article has been cited by other articles:

				C. Cooper, I. Carpenter, C. Katona, M. Schroll, C. Wagner, D. Fialova, and G. Livingston The AdHOC Study of Older Adults' Adherence to Medication in 11 Countries Am J Geriatr Psychiatry, December 1, 2005; 13(12): 1067 - 1076. [Abstract] [Full Text] [PDF]

				J. Gonzalez, J. W. Williams Jr., P. H. Noel, and S. Lee Adherence to Mental Health Treatment in a Primary Care Clinic J Am Board Fam Med, March 1, 2005; 18(2): 87 - 96. [Abstract] [Full Text] [PDF]

				C. I. Voils, D. C. Steffens, E. P. Flint, and H. B. Bosworth Social Support and Locus of Control as Predictors of Adherence to Antidepressant Medication in an Elderly Population Am J Geriatr Psychiatry, February 1, 2005; 13(2): 157 - 165. [Abstract] [Full Text] [PDF]

				S. K. Inouye, S. T. Bogardus Jr, C. S. Williams, L. Leo-Summers, and J. V. Agostini The Role of Adherence on the Effectiveness of Nonpharmacologic Interventions: Evidence From the Delirium Prevention Trial Arch Intern Med, April 28, 2003; 163(8): 958 - 964. [Abstract] [Full Text] [PDF]

				R. R. Bies, M. R. Gastonguay, K. C. Coley, P. D. Kroboth, and B. G. Pollock Evaluating the Consistency of Pharmacotherapy Exposure by Use of State-of-the-Art Techniques Am J Geriatr Psychiatry, December 1, 2002; 10(6): 696 - 705. [Abstract] [Full Text] [PDF]

				J. A. Bodkin and J. D. Amsterdam Transdermal Selegiline in Major Depression: A Double-Blind, Placebo-Controlled, Parallel-Group Study in Outpatients Am J Psychiatry, November 1, 2002; 159(11): 1869 - 1875. [Abstract] [Full Text] [PDF]

				J. DONOGHUE and T. R. HYLAN Antidepressant use in clinical practice: efficacy v. effectiveness The British Journal of Psychiatry, September 1, 2001; 179 (42): s9 - s17. [Abstract] [Full Text] [PDF]

				D. Owens, A. House, and C. Thompson Declarations of interestAuthor's reply The British Journal of Psychiatry, August 1, 2001; 179(2): 175 - 175. [Full Text] [PDF]

				R. Peveler and T. Kendrick Treatment delivery and guidelines in primary care: Depression and public health Br. Med. Bull., March 1, 2001; 57(1): 193 - 206. [Abstract] [Full Text] [PDF]

				C. THOMPSON Amitriptyline: still efficacious, but at what cost? The British Journal of Psychiatry, February 1, 2001; 178(2): 99 - 100. [Full Text] [PDF]

				How Do SSRIs and TCAs Stack Up Against Each Other? Journal Watch Psychiatry, May 1, 2000; 2000(501): 3 - 3. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us